Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Aug 17, 2015
Clinical News

Tenofovir alafenamide fumarate: Phase III data

BioCentury | Mar 17, 2014
Company News

Gilead sales and marketing update

BioCentury | Dec 6, 2013
Company News

G-BA says 'no additional benefit' for Stribild

BioCentury | Sep 18, 2013
Company News

IQWiG rebuffs Gilead's Stribild

BioCentury | Jul 2, 2013
Politics & Policy

WHO updates HIV recommendations

BioCentury | Jun 24, 2013
Regulation

Of cures & co-morbidities

FDA-drug developer conundrum: HIV patients reluctant to join cure trials
Items per page:
1 - 10 of 139